SANTA BARBARA , CA, UNITED STATES, November 8, 2024 /EINPresswire.com/ -- “High progesterone receptor positivity was linked to low grade tumors. Meningioma grade ...
Low-dose megestrol enhances hormone therapy for ER-positive breast cancer, reducing tumor proliferation and improving ...
Quantitative expression of ER and PgR and HER-2 status did not identify patients with differential relative benefit from anastrozole over tamoxifen: TTR was longer for anastrozole than for tamoxifen ...
In resource-limited settings, genomic assays for hormone receptor-positive, HER2-negative breast cancer aren't always accessible. Yet treatment decisions still need to be made -- often quickly and ...
A drug mimicking the hormone progesterone has anti-cancer activity when used together with conventional anti-estrogen ...